Final Report of the Safety Assessment of Lithium Stearate,Aluminum Distearate,Aluminum Stearate,Aluminum Tristearate,Ammonium Stearate,Calcium Stearate,Magnesium Stearate,Potassium Stearate,Sodium Stearate,and Zinc Stearate
Free accessResearch articleFirst published online March, 1982
Final Report of the Safety Assessment of Lithium Stearate,Aluminum Distearate,Aluminum Stearate,Aluminum Tristearate,Ammonium Stearate,Calcium Stearate,Magnesium Stearate,Potassium Stearate,Sodium Stearate,and Zinc Stearate
The commercial grade of stearic acid used in cosmetics contains fatty acids that range from C18 (stearic) and C22 (behenic). The concentrations of these ingredients used in cosmetic products vary from ≤ 0.1 to > 50%. Acute oral studies with rats indicated that the Stearates are practically nontoxic, and have a low potential for acute dermal toxicity. Skin irritation studies with rabbits demonstrated that Stearates are only minimal to slight irritants at high concentrations. Pharmaceutical vehicles containing 5.5% Magnesium Stearate were neither teratogenic nor mutagenic. In a limited study, Stearate did not increase bladder tumor incidence. Seven out of 20 subjects exhibited minimal to mild skin erythema when tested with an aqueous solution of 1.5% Ammonium Stearate. Similar results were obtained with Sodium Stearate at 0.5 percent. In a 21-day patch test with 10 subjects, an aqueous formulation containing 0.1-0.25% Sodium Stearate caused minimal skin irritation. No sensitization was reported in 100 subjects tested with the same formulation. On the basis of the available information presented in this report, and as qualified in the summary, it is concluded that the Stearate compounds described herein are safe as cosmetic ingredients.
References
1.
Cosmetic, Toiletry and Fragrance Association (CTFA). (April 17, 1979). Submission of data by CTFA. Stearates. Summary of unpublished safety data. Introduction.
2.
Cosmetic Ingredient Review (CIR). (April 27-29, 1979). Minutes of the CIR Expert Panel Meeting.
Hawley, G.G.(ed.). (1971). The Condensed Chemical Dictionary, 8th ed.NY: Van Nostrand Reinhold.
7.
Lorant, B. (1967). Thermoanalytical and thermogravimetric studies (of metal soaps). Seifen. Ole. Fette. Wachse.93(16), 547–51.
8.
Greenberg, LA., Lester, D. and Haggard, H. (1954). Handbook of Cosmetic Materials.NY: Inter-science Publishers.
9.
United States Pharmacopeial Convention. (1975). The United States Pharmacopeia, 19th ed. Rockville, MD.
10.
Windholz, M.(ed.). (1976). The Merck Index, 9th ed.Rahway, NJ: Merck and Co.
11.
Weast, R.C.(ed). (1978). CRC Handbook of Chemistry and Physics, 59th ed.West Palm Beach, FL: CRC Press.
12.
Kita, H., Ozuka, W., and Sugahara, G.(1956). Mechanism of the preparation of amides and nitriles from fatty acid and ammonia. II. Decomposition properties of ammonium soaps of fatty acids. Kogyo Kagaku Zasshi59, 1047–50.
National Formulary Board. (1975). The National Formulary, 14th ed.Washington, DC: American Pharmaceutical Association.
15.
National Academy of Sciences (NAS). (1972). Committee of Specifications, Food Chemical Codex, 2nd ed.Washington, DC: National Academy of Sciences.
16.
National Library of Medicine (NLM). (1979). Chemline, Computerized Database of the National Library of Medicine, Dept. of Health, Education and Welfare, Bethesda, MD,
17.
National Formulary Board. (1970). The National Formulary, 13th ed.Washington, DC: American Pharmaceutical Association.
18.
Rodionova, N.W., Zhukova, V.P. and Shmarlin, V.S.(1973). Determination of calcium stearate acid in butyl rubber by ir spectroscopy. Prom. Sin. Kauch., Nauch.-Tekhn. Sb.4, 3–5.
19.
Schroeder, E., Hagen, E., and Zysik, M.(1966). Analytical chemistry of plastics. XXXI. Flame photometric determination of calcium and barium stearate in structural plastics. Plaste Kaut.13(12), 712–13.
20.
Norwitz, G. and Gordon, H. (1972). Determination of lithium stearate in sebacate-base semifluid lubricants. Establishment of quality assurance requirements for lithium stearate. U.S. Nat. Tech. Inform. Serv. A.D. Rep. No. 751771:2, 21 pp.
21.
Norwitz, G. and Gordon, H.(1973). Determination of lithium stearate in sebacate-based lubricants by atomic absorption. Talanta20(9), 905–7.
22.
Zlateva, P. (1974). Analysis of zinc stearate. Kosh. Obuvna Prom.-St.15(5), 26–7.
23.
Balsam, M.S. and Sagarin, E. (eds.). (1974). Cosmetics. Science and Technology Vol. 2. NY: John Wiley and Sons.
24.
FDA. (Aug. 31, 1976). Cosmetic product formulation data. Washington, DC: Food and Drug Administration.
25.
Anonymous. (1976). Termination of provisional listing for color additives. Fed. Reg.41(186), 41855–56.
26.
FDA. FDA Inspection Operations Manual, March 26, 1979; updates Food Additives Status List to Feb. 15, 1979.
27.
FASEB. (1975). Select Committee on GRAS Substances. Evaluation of the health aspects of tallow, hydrogenated tallow, stearic acid, and calcium stearate as food ingredients. FDA Contract 233-75-2004. Bethesda, MD: Federation of American Societies for Experimental Biology.
28.
FASEB. (1976). Select Committee on CRAS Substances. Evaluation of the health aspects of magnesium salts as food ingredients. FDA Contract 223-75-2004. Bethesda, MD.
29.
Steels, W. and Jenski, H.M.(1974). Growth of Novikoff hepatoma cells in the presence of long-chain fatty acids. Proc. Soc. Exp. Biol. Med.146(3), 885–89.
30.
Acosta, D. and Webzel, D.G.(1974). Injury produced by free fatty acids to lysosomes and mitochondria in cultured heart muscles and endothelial cells. Atherosclerosis20(3), 417–26.
31.
Pilgeram, L.O. and Pickart, L.R.(1968). Control of fibrogen biosynthesis. The rule of free fatty acid. J. Atheroscler. Res.8(1), 155–66.
32.
Yamada, S. (1960). The influence of bile or bile acid on the absorption of insoluble calcium salts in intestinal tract. Eiyo To Shokuryo12, 391–403.
33.
Szakall, A. and Schulz, K.H.(1960). The penetration of the human skin by fatty alcohol sulfates and sodium soaps of fatty acids (C8-C18) and its relation to causes of irritation. Fette. Seifen. Anstrichm.62, 170–75.
34.
Howes, D. (1975). Percutaneous absorption of some anionic surfactants. J. Soc. Cosmet. Chem.26(1), 47–63.
35.
Morin, R.J. (1966). Incorporation of stearate-1-14C and oleate-1-14C into phosphatidylcholine and phos-phatidyethanolamine or rat liver mitochondria. Life Sci.5(7), 649–53.
36.
Avon Products. (Jan. 16, 1973). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate group. Oral toxicity.
37.
Avon Products. (Dec. 22, 1976). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate group. Biological Evaluation Summary Report. Zinc Stearate.
38.
Avon Products. (June 16, 1978). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate group. Biological Evaluation Summary Report. Aluminum Stearate.
39.
S.B. Penick and Co. (Aug. 3, 1976). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate group. Bio-Toxicology Laboratories. Acute oral LD50 toxicity study. Lithium Stearate.
40.
S.B. Penick and Co. (Feb. 9, 1977). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate group. Consumer Product Testing Co., Inc. Final Report. Magnesium Stearate.
41.
Hagan, E.C. (1959). Acute Toxicity. Appraisal of the safety of chemicals in foods, drugs, and cosmetics. Association of Food and Drug Officials of the U.S., as compiled by the staff of the Div. of Pharmacology, Food and Drug Administration, Dept. of Health, Education and Welfare, Austin, TX, pp. 17–25.
42.
Litchfield, J.R. and Wilcoxon, F. (1949) J. Pharmacol. Exp. Ther. pp. 96,99.
43.
CTFA. (June 16, 1975). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Group. Acute oral and dermal toxicity, Sodium Stearate. Product Type/ln-House Code: DS 5011-55 Stick Deodorant, Test No.: A-4644.
44.
CTFA. (Feb. 9, 1976). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Group. Acute oral intubation, acute dermal toxicity, primary skin irritation and ocular irritation.
45.
CTFA. (Feb. 6, 1978). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Group. Acute oral intubation, acute dermal toxicity, primary skin irritation and ocular irritation.
46.
CTFA. (July, 1978). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Group. Acute oral toxicity, Sodium Stearate. Bath soaps and detergents. Product 78-74.
47.
Avon Products. (March 27, 1975). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate group. Biological Evaluation Summary Report. Ammonium Stearate.
48.
CTFA: (March, 1970). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Group. Acute dermal toxicity, Sodium Stearate. Bath soaps and detergents. Product 78-74.
49.
S.B. Penick and Co. (Feb. 9, 1977). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate group. Consumer Product Testing Co., Inc. Final Report. Zinc Stearate.
50.
Draize, J.H., Woodard, G., and Calvery, H.O.(1944). Methods for the study of irritation and toxicity of substances, applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Ther.82, 377.
51.
Avon Products. (Jan. 4, 1973). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate group. Skin Irritation.
52.
Avon Products. (March 4, 1977). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate group. Biological Evaluation Summary Report. Aluminum Distearate.
53.
Draize, J.H. (1959). Dermal Toxicity. Appraisal of the safety of chemicals in foods, drugs, and cosmetics. Assoc, of Food and Drug Officials of the U.S., compiled by the staff of the Div. of Pharmacology, Food and Drug Administration, Dept. of Health, Education and Welfare, Austin, TX, pp. 46–59.
54.
CTFA. (May 27, 1975). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Croup. Primary irritancy, Sodium Stearate. Product Type/ln-House Code: DS 5011-55 Stick Deodorant, Test No.: A-4644.
55.
CTFA. (May, 1978). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Croup. Eye and lower case primary skin irritation, Sodium Stearate. Bath soaps and detergents. Product 78-74.
56.
Avon Products. (Jan. 8, 1973). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate group. Draize eye test.
57.
CTFA. (June 4, 1975). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Croup. Eye irritancy, Sodium Stearate. Product Type/ln-House Code: DS 5011-72 Stick Deodorant, Test No.: A-4644.
58.
Graham, J.D.P. and Jenkins, M.E.(1952). Effects of substitutes for surgical talc on wounds. J. Pharm. Pharmacol.4, 392–98.
59.
Connor, W.E., Hoak, J.C., and Warner, E.D.(1963). Massive thrombosis produced by fatty acid infusion. J. Clin. Invest.42(6):860–66.
60.
Day, H.J., Fewell, W., and Soloff, L.A.(1967). Thrombosis in the dog produced by single rapid infusions of long chain saturated fatty acids. Am. J. Med. Sci.253(1), 113–23.
61.
Hoak, J.C. (1964). Structure of thrombi produced by injection of fatty acids. Brit. J. Exp. Pathol.45,44–7.
62.
Prost, R.J., Dvojakovic, M.Bara, L, and Samama, M. (1972). Effects of saturated and unsaturated fatty acids on blood platelet aggregation in vitro and after injection into rabbits. Acta Univ. Carol., Med. Monogr.53/54, 403–7.
63.
Pollack, O.J. and Wadler, B.(1951), Experimental atherosclerosis. III. Anatomic alterations induced by intravascular injection of the cholesterol sols into animals. J. Gerontol.6, 217–28.
64.
Harding. H.E. (1958). Some inquiries into the toxicology of zinc stearate. Brit. J. Ind. Med.15, 130–32.
65.
Tarasenko, N.Y., Shabalina, L.P., and Spiridonova, V.S.(1976). Comparative toxicity of metal stearates. Int. Arch. Occup. Environ. Health37(3), 179–92.
66.
CTFA. (May, 1970). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Group. Three-month dermal toxicity, Sodium Stearate. Bath soaps and detergents. Product 78-74.
67.
Gottschewski, G.H.M. (1967). Can carriers of active ingredients in coated tablets have teratogenic effects? Arzneim. Forsch.17, 1100–103.
68.
Litton Bionetics. (1976). Mutagenic evaluation of compound FDA 75-33, magnesium stearate. Report prepared under DHEW contract no. FDA 223-74-2104, Kensington, MD.
69.
Swern, D., Weider, R., Mcdonough, M., Merance, D.R., and Skimkin, M.B.(1970). Investigation of fatty acids and derivatives for carcinogenic activity. Cancer Res.30, 1037–46.
70.
Clayson, D.B. (1962). Chemical Carcinogenesis, p. 341. Boston, MA: Little, Brown and Co.
71.
Van Duuren, B.L., Katz, C., Shimkin, M.B., Swern, D., and Wieder, R. (1972). Replication of low-level carcinogenic activity bioassays. Cancer Res.32, 880–81.
72.
Deichmann, W.B., Radomski, J.L., Macdonald, W.E., Kascht, R.L., and Erdmann, R.L.(1958). The chronic toxicity of octadecylamine. Arch. Industr. Health18, 483–87.
73.
Boyland, E., Busby, E.R., Dukes, C.E., Grover, P.L., and Manson, D.(1964). Further experiments on implantation of materials into the urinary bladder of mice. Brit. J. Cancer18(3), 575–81.
74.
Avon Products. (March 13, 1975). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate group. Clinical Evaluation Report: Human Patch Test. Ammonium Stearate.
75.
Avon Products. (Jan. 16, 1973). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate group. Evaluation of the Irritancy Potential of Sodium Stearate C-6.
76.
CTFA. (June 13, 1978). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Group. Primary Irritancy/Sensitization, Sodium Stearate. Product Type/ln-House Code: DS 5011-0 Stick Deodorant. Test No.: H-1452.
77.
CTFA. (July, 1978). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Group. Primary Irritancy/Sensitization, Sodium Stearate. Product Type/ln-House Code: DS 5011-0 Stick Deodorant. Test No.: H-1478.
78.
CTFA. (Nov., 1978). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Group. Primary Irritancy/Sensitization, Sodium Stearate. Product Type/ln-House Code: DS 5011-0 Stick Deodorant. Test No.: H-1525.
79.
CTFA. (July, 1975). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Group. Twenty-one day human cumulative irritation, Sodium Stearate. Bath soaps and detergents. Product 78-74.
80.
CTFA. (Oct. and Dec. 1975). Submission of data by CTFA. Unpublished safety data on Lithium Stearate Group. Human skin sensitization, Sodium Stearate. Bath soaps and detergents. Product 78-74.
81.
CTFA. (March 26, 1976). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Group. Schwartz-Peck Prophetic Patch Test and Draize-Shelanski Repeated Insult Patch Test. Zinc Stearate (10 percent) in eyeshadow 923-100.
82.
CTFA. (March 29, 1978). Submission of data by CTFA. Unpublished safety data on the Lithium Stearate Group. Schwartz-Peck Prophetic Patch Test and Draize-Shelanski Repeated Insult Patch Test. Zinc Stearate (10 percent) in eyeshadow 923-100.
83.
CTFA. (Jan. 24, 1977). Submission of data by CTFA. Unpublished safety data on Lithium Stearate Group. Human usage test. Zinc Stearate (10 percent) in eyeshadow 923-100.
84.
Hurley, H.J. and Shelley, W.(1959). The colloidal state as a stimulus for non-allergic epitheloid granulomas: experimental studies in man with pure sodium stearate and palmitate. J. Invest. Dermatol.33(4), 203–19.
85.
Schmidt-Wilcke, H.A., Steinhagen, P., Steinhagen, E., and Martini, G.A. (1975). Effect of fatty acids on the stimulated gastric secretion in man. Digestion13(1-2), 8–14.
86.
Weber, J., Einbrodt, H.J., and Wewer, B.(1976). Can zinc stearate cause lung fibrosis? (Case report). Beitr. Silikoseforsch.28(2), 103–16.
87.
Murray, L.M. (1926). Analysis of sixty cases of drug poisoning. Arch. Pediatrics43, 193–96.
88.
Heiman, H. and Aschner, P.W.(1922). The aspiration of stearate of zinc in infancy. A clinical and experimental study. Am. J. Dis. Child.0, 503–10.
89.
Gosselin, R.E., Hodge, H.C., Smith, R.P., and Gleason, M.N.(1976). C/inica/ Toxicology of Commercial Products, 4th ed.Baltimore, MD: Williams and Wilkins Co.
